Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia- COST
|Effective start/end date||3/1/21 → 2/28/23|
- CLEVELAND CLINIC
- NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.